Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The British Journal of Dermatology|December 18, 2021
Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohortsJulia Steinberg, Mark M Iles, Jin Yee Lee, et al.
European Journal of Human Genetics : EJHG|February 26, 2025
Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participantsDavid E Goldsbury, Yoon-Jung Kang, Catherine Tang, et al.
BMC Medicine|October 23, 2023
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policiesNatansh D Modi, Ganessan Kichenadasse, Tammy C Hoffmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2016
A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the PublicAmelia K Smit, David Espinoza, Ainsley J Newson, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
Contemporary Clinical Trials|May 27, 2018
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviorsAmelia K Smit, Ainsley J Newson, Rachael L Morton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trialAmelia K Smit, Martin Allen, Brooke Beswick, et al.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
JAMA Dermatology|November 24, 2021
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical TrialDeonna M Ackermann, Mbathio Dieng, Ellie Medcalf, et al.
Pageof 5